Showing results (271-280 of 463) with videos related to

Sort By:
Pageof 47
International Journal of Hematology|September 19, 2017
Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016Akiko Miyagi Maeshima, Hirokazu Taniguchi, Tomotaka Suzuki, et al.
Virchows Archiv : an International Journal of Pathology|February 13, 2024
Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapyYuto Kaimi, Yuka Takahashi, Hirokazu Taniguchi, et al.
Pathology International|July 23, 2019
EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomasYuta Ito, Shinichi Makita, Akiko Miyagi Maeshima, et al.
Endoscopy|October 15, 2014
Clinical outcome of endoscopic resection for nonampullary duodenal tumorsSatoru Nonaka, Ichiro Oda, Kazuhiro Tada, et al.
Leukemia & Lymphoma|October 16, 2014
Clinicopathological characteristics of follicular lymphoma with peripheral blood involvementAkiko Miyagi Maeshima, Hirokazu Taniguchi, Kensaku Tanioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case of Advanced Gastric Cancer with Peritoneal Metastasis Achieved Pathological Complete Response by Chemotherapy(SOX Regimen)]Takahiko Nishigaki, Yoshio Oka, Hirokazu Taniguchi, et al.
European Journal of Haematology|July 12, 2011
Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institutionSuguru Fukuhara, Takashi Watanabe, Wataru Munakata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy]Yutaka Kimura, Hirokazu Taniguchi, Shoichiro Fujita, et al.
The Journal of International Medical Research|May 31, 2015
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective studyKensuke Suzuki, Hideaki Furuse, Takeshi Tsuda, et al.
Oncotarget|December 31, 2015
Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancerNaoki Takahashi, Koh Furuta, Hirokazu Taniguchi, et al.
Pageof 47